Ron Sabo

A Dose-Ranging Study of Pegylated Interferon Alfa-2b and Ribavirin in Chronic Hepatitis C

Paul Glue, Régine Rouzier‐Panis, C Raffanel et al. · Hepatology · 2000 · 248 citations · Full text

Pharmacodynamics of subcutaneous recombinant human interleukin-10 in healthy volunteers*

Richard D. Huhn, Elaine Radwanski, Jose Gallo et al. · Clinical Pharmacology & Therapeutics · 1997 · 129 citations

The Absolute Oral Bioavailability and??Population-Based Pharmacokinetic Modelling of a Novel Dipeptidylpeptidase-IV Inhibitor, Vildagliptin, in Healthy Volunteers

Yanling He, Brian M. Sadler, Ron Sabo et al. · Clinical Pharmacokinetics · 2007 · 74 citations

Pharmacokinetic Modeling, Novel Dipeptidylpeptidase-iv Inhibitor, Healthy Volunteers +8

The effect of age, gender, and body mass index on the pharmacokinetics and pharmacodynamics of vildagliptin in healthy volunteers

Yanling He, Ron Sabo, Joelle Campestrini et al. · British Journal of Clinical Pharmacology · 2007 · 65 citations · Full text

The influence of hepatic impairment on the pharmacokinetics of the dipeptidyl peptidase IV (DPP-4) inhibitor vildagliptin

Yanling He, Ron Sabo, Joelle Campestrini et al. · European Journal of Clinical Pharmacology · 2007 · 64 citations

Liver Physiology, Pharmacology, Hepatic Impairment +8